Elixirgen Scientific Revenue and Competitors
Estimated Revenue & Valuation
- Elixirgen Scientific's estimated annual revenue is currently $3.7M per year.
- Elixirgen Scientific's estimated revenue per employee is $155,000
Employee Data
- Elixirgen Scientific has 24 Employees.
- Elixirgen Scientific grew their employee count by 0% last year.
Elixirgen Scientific's People
Name | Title | Email/Phone |
---|
Elixirgen Scientific Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Elixirgen Scientific?
Elixirgen Scientific, launched in 2016, is a Baltimore-based biotechnology company focused on stem cell related technology. The company’s mission is to make stem cell innovation available to everyone. The industry’s top issue is the high cost and and inefficiencies in iterating research and development due to the long cell differentiation period from human pluripotent stem cells to specific human cells. The company is now providing reagents and kits at an affordable price to help make research and other laboratory work more efficient. Elixirgen Scientific, LLC is located in the Science + Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Scientific’s scientists to conduct research at state-of-the-art facilities.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 24 | -43% | $12.9M |
#2 | $3.7M | 24 | 9% | N/A |
#3 | $3.5M | 24 | -17% | N/A |
#4 | $4.5M | 24 | -14% | N/A |
#5 | $3.8M | 24 | 4% | N/A |